文献速递糖尿病肥胖与代谢综合征

肥胖个体糖尿病治疗中的药物使用

Medication use for the treatment of diabetes in obese individuals.
PubMed 文献 · Diabetologia · 2017-05-14

本文综述了肥胖合并糖尿病患者体重管理的药物策略。减重对血糖控制有益,但磺脲类、噻唑烷二酮类和胰岛素可能妨碍减重。生活方式支持是主要方法,也可考虑选择体重中性或减重类降糖药,或使用获批的抗肥胖药物;GLP-1受体激动剂和SGLT2抑制剂兼有降糖与减重作用,使两类药物界限渐趋模糊。

要点

  • 减重可改善肥胖糖尿病患者的血糖控制,2型糖尿病有时可接近血糖代谢正常化。
  • 磺脲类、噻唑烷二酮类和胰岛素等降糖治疗可能妨碍减重。
  • 生活方式支持是减重的主要方法,也可考虑体重中性或减重类降糖药及获批抗肥胖药物。

核心结论

  • 减重对肥胖糖尿病患者有诸多健康益处,常改善血糖控制,2型糖尿病有时可接近血糖代谢正常化。
  • 生活方式支持应是帮助减重个体的主要方法,药物治疗也可考虑。
  • GLP-1受体激动剂和SGLT2抑制剂等减重降糖药也正被用于或考虑用作抗肥胖药物,降糖药与减重药界限渐趋模糊。

研究设计与样本

  • 综述,讨论可用于支持糖尿病患者减重的主要药物方法。

主要发现

  • 减重难以维持,磺脲类、噻唑烷二酮类和胰岛素等降糖治疗可能削弱减重努力。
  • 可选择体重中性或导致体重下降的降糖药或药物组合,或处方专门获批的抗肥胖药物。
  • GLP-1受体激动剂和SGLT2抑制剂等较新降糖药因具减重作用,也正被用于或考虑用作抗肥胖药物。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is a major cause of type 2 diabetes and may complicate type 1 diabetes. Weight loss for obese individuals with diabetes has many health benefits, often leads to improvement in glucose control and sometimes, in type 2 diabetes, near normalisation of abnormal glucose metabolism. Weight loss is difficult to maintain and attempts to lose weight may be undermined by some diabetes treatments such as sulfonylureas, thiazolidinediones and insulin. Whilst lifestyle support should be the primary approach to aid individuals who wish to lose weight, pharmacological approaches can also be considered. These include choosing glucose-lowering drugs or drug combinations that are weight neutral or result in weight loss or prescribing drugs that are specifically approved as anti-obesity medication. Given that some of the newer glucose-lowering medications that cause weight loss, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2i), are also being used or considered for use as anti-obesity drugs, it seems that the distinction between glucose-lowering medication and weight loss medication is becoming blurred. This review discusses the main pharmacological approaches that can be used to support weight loss in individuals with diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Wilding JPH. Medication use for the treatment of diabetes in obese individuals. Diabetologia. 2017. PMID: 28501906. doi:10.1007/s00125-017-4288-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。